In the first of a two-part interview, LeafCann chief executive Elisabetta Faenza tells Cannabiz how a rare genetic condition in childhood shaped her interest in medicine and propelled her quest for plant-based solutions.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Elisabetta Faenza remembers the moment well. It arrived during yet another visit with her mum to an Italian hospital. Sitting in a consultant’s office, both mother and daughter listened to the prognosis for Elisabetta, then just 11 years old.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...